Fast dispatch is a service measure. Product integrity depends on whether the material remains within conditions supported by its stability evidence. A parcel can arrive quickly after an unsuitable temperature excursion, while a longer shipment may be acceptable in a qualified packaging system. Delivery speed alone cannot resolve either case.

A useful shipping assessment begins before the parcel leaves. Identify the exact material, container and stability specification. Ask what evidence supports the proposed transport conditions and how departures from those conditions will be assessed. ICH stability guidance connects storage claims to systematic testing rather than appearance or convenience. EMA: ICH Q1A(R2), stability testing

For temperature-sensitive medicines, FDA has specifically raised concerns about inadequate refrigeration during shipping of certain injectable GLP-1 products. FDA: Concerns with unapproved GLP-1 drugs That warning should not be turned into a universal temperature rule for every peptide. Different products, formulations and containers need their own validated requirements.

When a research shipment arrives, the laboratory can document the lot, package condition, transit information and any supplied monitoring record under its receipt procedures. A damaged package or unresolved excursion should be escalated to the responsible quality personnel. Touching a vial and deciding that it feels cold is not an analytical release test.

An informative supplier service comparison therefore separates dispatch promise, carrier performance and stability assurance. It should state what the seller guarantees, what it measures and what happens when the evidence is incomplete. No generic shelf life, storage temperature or rescue procedure is provided here. The central question is whether this particular lot's transport history is consistent with a supported specification, and whether that conclusion can be reconstructed later from records.